Head-to-head comparisons of medication uses, side effects, warnings, and more.
Riluzole (Rilutek) and edaravone (Radicava) are both medications used to treat amyotrophic lateral sclerosis (ALS), a condition that affects nerve cells in the brain and spinal cord. While they share this indication, they differ in several ways. Riluzole is a glutamate antagonist that helps slow the progression of ALS by reducing glutamate levels, and it is available in tablet, liquid, and oral film forms. Edaravone, on the other hand, is thought to have antioxidant properties and is available as an intravenous infusion or oral suspension. Riluzole is typically taken twice a day, while edaravone follows a more complex dosing schedule with cycles of daily doses followed by breaks. Riluzole is available as a lower-cost generic for the tablet form, whereas edaravone is only available as a brand-name medication, which can be expensive. Common side effects of riluzole include mouth numbness and nausea, while edaravone can cause headaches and skin irritation. Additionally, edaravone carries a risk of severe allergic reactions, especially in those with sulfite allergies.
Riluzole (Rilutek) helps slow down worsening of symptoms in people with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. It doesn't improve symptoms, but people taking the medication may be able to slow their need for a breathing tube and live about 2 to 3 months longer. It also comes as a liquid and oral film for people who have trouble swallowing pills.
Radicava (edaravone) is one of only a few available treatment options for amyotrophic lateral sclerosis (ALS). It's either given as a liquid suspension taken by mouth or as an injection into your veins. It's available as a brand-name medication only, which can be expensive.
^*Side effects reported with IV infusion. Side effects for the oral suspension might differ.^
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.